Covington & Burling advised an affiliate of OrbiMed Advisors on the transaction. OrbiMed Advisors announced its agreement to purchase 100% of Neurelis Inc.’s rights, royalty interests,...
You must be a Standard 1 Year member to access this content.
Covington & Burling advised Omeros Corporation on the deal, and King & Spalding and Paul Hastings represented the lenders. Omeros Corporation (Omeros) (Nasdaq: OMER) announced it...
You must be a Standard 1 Year member to access this content.
Covington advised Humacyte on the deal. Humacyte, Inc. announced its $150 million revenue-based funding arrangement, as well as a $10 million equity investment option, with Oberland...
You must be a Standard 1 Year member to access this content.
Covington advised Insmed Incorporated on the deal while Fenwick represented Pharmakon. Walder Wyss advised the funds managed by Pharmakon Advisors, LP, BioPharma Credit and OrbiMed. Akin...
You must be a Standard 1 Year member to access this content.
Covington advised Marathon Asset Management LP on the deal. Marathon Asset Management LP announced a non-dilutive term loan for up to $100 million to Theratechnologies Inc. Marathon...
You must be a Standard 1 Year member to access this content.
